GIUDICE, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 3.044
EU - Europa 924
AS - Asia 412
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 7
AF - Africa 6
SA - Sud America 5
Totale 4.406
Nazione #
US - Stati Uniti d'America 3.035
IT - Italia 462
CN - Cina 172
IE - Irlanda 128
UA - Ucraina 115
VN - Vietnam 112
DE - Germania 70
TR - Turchia 56
GB - Regno Unito 39
SE - Svezia 38
IN - India 34
FI - Finlandia 31
CA - Canada 9
EU - Europa 8
CZ - Repubblica Ceca 7
ID - Indonesia 7
NP - Nepal 7
FR - Francia 6
SG - Singapore 6
AU - Australia 5
ES - Italia 5
KR - Corea 5
EC - Ecuador 4
HK - Hong Kong 4
PL - Polonia 4
TH - Thailandia 4
AT - Austria 3
ET - Etiopia 3
LU - Lussemburgo 3
MK - Macedonia 3
BE - Belgio 2
HU - Ungheria 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
BR - Brasile 1
CH - Svizzera 1
DZ - Algeria 1
EG - Egitto 1
GR - Grecia 1
HR - Croazia 1
JP - Giappone 1
MA - Marocco 1
MY - Malesia 1
NL - Olanda 1
PH - Filippine 1
RS - Serbia 1
SI - Slovenia 1
Totale 4.406
Città #
Ann Arbor 469
Chandler 459
Woodbridge 326
Princeton 309
Ashburn 237
Wilmington 189
Houston 156
Jacksonville 147
Naples 116
Dong Ket 112
Dublin 112
Salerno 68
Andover 57
Izmir 56
Beijing 47
Redwood City 35
Nanjing 34
Washington 33
Boardman 27
Pellezzano 23
Pune 22
Düsseldorf 18
Fairfield 18
Changsha 16
Norwalk 15
Seattle 13
Nanchang 12
Cava De' Tirreni 10
Lappeenranta 10
Manchester 9
Tianjin 9
Cambridge 8
Caserta 8
Shenyang 8
Brno 7
Kathmandu 7
Richmond 7
Catania 6
Dearborn 6
Fisciano 6
Guangzhou 6
San Prisco 6
Edinburgh 5
Jiaxing 5
London 5
Mercato San Severino 5
Napoli 5
Piacenza 5
Rochester 5
San Diego 5
Toronto 5
Cava de' Tirreni 4
Cellole 4
Chiang Mai 4
Hebei 4
Lentini 4
Madrid 4
Menlo Park 4
Munich 4
Palermo 4
Pescara 4
Quito 4
Teano 4
Wenzhou 4
Addis Ababa 3
Arienzo 3
Aversa 3
Bagno A Ripoli 3
Delhi 3
Esslingen am Neckar 3
Falls Church 3
Glasgow 3
Gunzenhausen 3
Hefei 3
Marano Di Napoli 3
Mestre 3
Milan 3
New York 3
Rome 3
Rovereto 3
Southend 3
Trieste 3
Turin 3
Vienna 3
Warsaw 3
Acireale 2
Arzano 2
Bacoli 2
Baltimore 2
Bologna 2
Castel San Lorenzo 2
Chandigarh 2
Desio 2
Dormagen 2
Ferrara 2
Frankfurt am Main 2
Grumo Nevano 2
Guwahati 2
Indiana 2
Indianapolis 2
Totale 3.429
Nome #
High incidence of cytomegalovirus reactivation in patients with lymphoma treated with bendamustine 127
Lenalidomide-Mediated NK Cells Expansion In Elderly Multiple Myeloma Patients 125
Autologous And Allogeneic Stem Cell Transplantation Is Associated With Long-Lasting Endocrine Disorders 118
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation increases the number of circulating natural killer cells 114
Accelerated and persistent bone loss after autologous and allogeneic stem cell transplantation 109
Anaplastic CD30+ alk- (micro) lymphoma arising out of mediastinal Plasma Cell Castleman’s disease in immunocompetent patient treated by rituximab- dexametasone and continuous lenalidomide 102
Involvement of soluble forms of receptor of the urokinase-type plasminogen activator (UPAR) in hematopoietic stem cell homing 102
Prolonged low-dose lenalidomide treatment increases the number of circulating natural killer cells in multiple mieloma patients 101
Prolonged azacitidine treatment in the management of elderly patients with high risk myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia not eligible for standard intensive therapy 99
Induction therapy with continuous alternate-day low dose lenalidomide combined with low-dose prednisone in octogenarian Multiple Myeloma patients 95
Prophylactic therapy with oral low-dose valgancyclovir in cytomegalovirus-positive allogeneic stem cell transplant recipients 94
Cytomegalovirus reactivation prophylaxis with low dose valgancyclovir after hematopoietic stem cell transplantation 90
Endocrine disorders after autologous and allogeneic stem cell transplantation 86
Urokinase type plasminogen activator receptor (UPAR) as a new therapeutic target in cancer. 86
Daily low-dose valgancyclovir is safe and effective CMV-reactivation prophylaxis in HLA-identical sibling hematopoietic stem cell transplantation. Bone Marrow Transplantation 85
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation 83
67 KDA laminin receptor (67LR) in normal and neoplastic hematopoietic cells: is its targeting a feasible approach? 82
Flow Cytometric Detection Of B-cell Membrane Markers CD5, CD11c, CD20, CD38 And CD49d May Predict Outcome In Chronic Lymphocytic Leukemia And Non-Hodgkin Lymphoma 82
Sirt-1 as a novel therapeutic target for improving nitric oxide release in heterozygous and homozygous patients for mthfr mutations 76
In vitro apoptotic effects of farnesyltransferase blockade in acute myeloid leukemia cells. 76
Bone marrow mesenchymal stem cells as a possible ruxolitinib reservoir in the bone marrow niche 74
Gender differences in pharmacokinetics of levodopa in Parkinson’s disease 74
Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells. 71
Role of Laparoscopic Splenectomy in Elderly Immune Thrombocytopenia. 71
Combined liposomal amphotericin b and surgery as successful management for pulmunary mucormycosis in a patient with acute myeloid leukemia 67
Prolonged complete hematologic response in relapsed/refractory T-large granular lymphocyte leukemia after bendamustine treatment. 67
Reproductive issues in patients undergoing Hematopoietic Stem Cell Transplantation: an update 66
Efficacy and safety of splenectomy in adult autoimmune hemolytic anemia. 61
Low-dose valgancyclovir as cytomegalovirus reactivation prophylaxis in allogeneic hematopoietic stem cell transplantation 59
Low-dose valgancyclovir as cytomegalovirus reactivation prophylaxis in allogeneic haematopoietic stem cell transplantation. 58
Daily low-dose valgancyclovir is safe and effective CMV-reactivation prophylaxis in HLA-identical sibling hematopoietic stem cell transplantation 56
Bone Marrow Failure Syndromes, Overlapping Diseases with a Common Cytokine Signature 54
Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases 51
Successful management of pulmonary mucormycosis with liposomal amphotericin B and surgery treatment: a case report 47
Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens 46
Immunohistochemical algorithms and gene expression profiling in primary cutaneous B-cell lymphoma 46
Therapeutic drug monitoring might identify poor responders to ruxolitinib treatment in myeloproliferative neoplasms 45
Real-world experience with the Sydney System on 1458 cases of lymph node fine needle aspiration cytology 45
Effects of selected preanalytical variables on Dried Blood Spot (DBS) and Volumetric Adsorptive Microsampling (VAMS) based bioanalytical methods for the determination of four β-lactam antibiotics 44
3D Biomimetic Scaffold for Growth Factor Controlled Delivery: An in-vitro study of Tenogenic events on Wharton’s Jelly Mesenchymal stem cells 44
How to Improve the Definition of Chronic Lymphocytic Leukemia Outcome Using a Simple Flow Cytometric Score Based on CD49d and Homing Marker Expression 42
Can we turn off the “Covid-biting-tail” inflammation? 41
Stem cell and macrophage roles in skeletal muscle regenerative medicine 38
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study 37
A simple flow cytometric score based on CD49d and homing marker expression in chronic lymphocytic leukemia (CLL). 36
Mucosal-Associated Invariant T Cells in T-Cell Non-Hodgkin Lymphomas: A Case Series 33
Aplastic anemia: Pathophysiology 33
Identification of uPAR Variants Acting as ceRNAs in Leukaemia Cells 33
Axitinib in Ponatinib-Resistant B-Cell Acute Lymphoblastic Leukemia Harboring a T315L Mutation 32
Chondrogenic Commitment of human Bone Marrow Mesenchymal Stem Cells in a perfused, hTGF-β1-releasing PLGA microcarrier seeded, collagen hydrogel 32
Post-Transplant Cyclophosphamide (PTCY) as GVHD Prophylaxis for Hematopoietic Stem Cell Transplantation From Matched-Related Sibling Donors 32
OPSI threat in hematological patients 32
Aptamer-based proteomics of serum and plasma in acquired aplastic anemia 31
Myogenic commitment of human stem cells by myoblasts Co-culture: a static vs. a dynamic approach 31
The Role of B Regulatory Cells in the Immunological Escape of Tumor Cells in Hodgkin Lymphoma 30
Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters 30
A case series of blastic plasmacytoid dendritic cell neoplasia 29
Single Cell RNA Sequencing and V(D)J Profiling of T-Cell Large Granular Lymphocytosis. 29
Lymph node fine-needle cytology in the era of personalised medicine. Is there a role? 28
WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes 27
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency 26
Sex-tailored pharmacology and COVID-19: next steps towards appropriateness and health equity 26
Peripheral blood mononuclear cells contribute to myogenesis in a 3D bioengineered system of bone marrow mesenchymal stem cells and myoblasts 25
High throughput pSTAT signaling profiling by fluorescent cell barcoding and computational analysis 25
Cardiotoxicity of Novel Targeted Hematological Therapies 25
Fluorescent Cell Barcoding for Immunophenotyping 25
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 24
Gender Differences in the Impact of COVID-19 Pandemic on Mental Health of Italian Academic Workers 24
Kaposi's sarcoma associated with chronic myeloid leukemia and imatinib mesylate therapy 24
Circulating exosomal microRNAs in acquired aplastic anemia and myelodysplastic syndromes 21
The value of flow cytometry clonality in large granular lymphocyte leukemia 21
Efficacy of Decitabine and Venetoclax as Salvage and Bridge Therapy to Haploidentical Hematopoietic Stem Cell Transplantation in a Multiresistant Acute Myeloid Leukemia Patient 20
Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndrome 20
Prophylactic letermovir decreases cytomegalovirus reactivation after stem cell transplantation: a single-center real-world evidence study 20
Single-cell RNA sequencing coupled to TCR profiling of large granular lymphocyte leukemia T cells 20
Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma 20
Eltrombopag Improves Hematopoiesis in Patients with Low to Intermediate-2 Risk Myelodysplastic Syndrome (MDS). 19
3D in-vitro cultures of human bone marrow and Wharton’s jelly derived mesenchymal stromal cells show high chondrogenic potential 18
Implementation of International Prognostic Index with flow cytometry immunophenotyping for better risk stratification of chronic lymphocytic leukemia 18
Persistent decreased bone marrow CD3+CD56+ T lymphocytes are inversely associated with mature granulocytes in myelodysplastic syndromes 17
Fluorescent Cell Barcoding As New Flow Cytometric Technique for Multiplexed Phenotyping and Signaling Profiling in Hematologic Patients 17
Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study 16
Inter-intra instrument comparison and standardization of a 10-color immunophenotyping for B and T cell non-Hodgkin lymphoma diagnosis and monitoring 16
Stem Cells from Healthy and Tendinopathic Human Tendons: Morphology, Collagen and Cytokines Expression and Their Response to T3 Thyroid Hormone 16
Pharmacovigilance of Selective Serotonin Reuptake Inhibitors and Gender Differences in Stroke Incidence 15
SERUM FREE LIGHT CHAIN RATIO AS A BIOMARKER OF MULTIPLE MYELOMA PROGRESSION AND ASSOCIATED RENAL DISEASE 14
Hemopoiesis and Immune Cell Perturbations during Venetoclax Plus Azacytidine Treatment in Acute Myeloid Leukemia 14
Clinical efficacy of azacytidine and venetoclax and prognostic impact of Tim-3 and galectin-9 in acute myeloid leukemia and high-risk myelodysplastic syndromes: A single-center real-life experience 14
CRISPR/Cas9-Induced DNM3TA Mutations in the K562 Human Leukemic Cell Line as a Model of DNMT3A-Mutated Leukemogenesis 14
Risk and Prognostic Factors of Extra-Nodal Hodgkin Lymphoma: Single Jordanian Center Experience. 14
Infectious Agents and Bone Marrow Failure: A Causal or a Casual Connection? 14
Low-Density Granulocytes Are Decreased in Acute Myeloid Leukemia and in Myelodysplastic Syndromes with Negative Prognostic Factors 13
Secretory and Membrane-Associated Biomarkers of Mast Cell Activation and Proliferation 13
Circulating S100A8 and S100A9 protein levels in plasma of patients with acquired aplastic anemia and myelodysplastic syndromes 13
Immunologic effects on the haematopoietic stem cell in marrow failure 13
Reduced Proliferative Potential with Conserved Stem/Stromal Phenotype of Human Umbilical Cord Mesenchymal Stem Cells in Placental Syndromes: A Prospective Cohort Study 12
Multiple myeloma characteristics correlated to serum free light chain ratio at diagnosis and association with early renal damage 12
Hodgkin Lymphoma and Hairy Cell Leukemia Arising from Chronic Lymphocytic Leukemia: Case Reports and Literature Review 12
Oligoclonal Expansion of Effector Memory CD8+CD57+ T Cells May Sustain Bone Marrow Destruction in Aplastic Anemia 12
Giant plasma cells with multiple immature nuclei in a young woman with newly diagnosed multiple myeloma 12
Totale 4.448
Categoria #
all - tutte 15.499
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.499


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201978 0 0 0 0 0 0 0 0 8 6 64 0
2019/2020281 72 3 33 5 17 16 29 0 23 20 51 12
2020/2021544 10 29 25 2 103 28 42 11 38 43 71 142
2021/2022590 14 2 20 43 17 16 5 19 74 51 75 254
2022/20231.205 95 110 89 130 112 212 54 124 161 4 61 53
2023/2024708 79 90 73 60 83 164 71 71 17 0 0 0
Totale 4.646